Literature DB >> 19713960

Regulation of nucleolar signalling to p53 through NEDDylation of L11.

Anders Sundqvist1, Geng Liu, Antonis Mirsaliotis, Dimitris P Xirodimas.   

Abstract

Several studies have shown that ribosomal proteins (RPs) are important mediators of p53 activation in response to nucleolar disruption; however, the pathways that control this signalling function of RPs are currently unknown. We have recently shown that RPs are targets for the ubiquitin-like molecule NEDD8, and that NEDDylation protects RPs from destabilization. Here, we identify NEDD8 as a crucial regulator of L11 RP signalling to p53. A decrease in L11 NEDDylation during nucleolar stress causes relocalization of L11 from the nucleolus to the nucleoplasm. This not only provides the signal for p53 activation, but also makes L11 susceptible to degradation. Mouse double minute 2 (MDM2) -mediated NEDDylation protects L11 from degradation and this is required for p53 stabilization during nucleolar stress. By controlling the correct localization and stability of L11, NEDD8 acts as a crucial, new regulator of nucleolar signalling to p53.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19713960      PMCID: PMC2759733          DOI: 10.1038/embor.2009.178

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  20 in total

1.  Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo.

Authors:  D Xirodimas; M K Saville; C Edling; D P Lane; S Laín
Journal:  Oncogene       Date:  2001-08-16       Impact factor: 9.867

2.  Regulation of HDM2 activity by the ribosomal protein L11.

Authors:  Marion A E Lohrum; Robert L Ludwig; Michael H G Kubbutat; Mary Hanlon; Karen H Vousden
Journal:  Cancer Cell       Date:  2003-06       Impact factor: 31.743

3.  Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity.

Authors:  Dimitris P Xirodimas; Mark K Saville; Jean-Christophe Bourdon; Ronald T Hay; David P Lane
Journal:  Cell       Date:  2004-07-09       Impact factor: 41.582

4.  A dominant-negative UBC12 mutant sequesters NEDD8 and inhibits NEDD8 conjugation in vivo.

Authors:  H Wada; E T Yeh; T Kamitani
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

5.  Cocompartmentalization of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53.

Authors:  D P Xirodimas; C W Stephen; D P Lane
Journal:  Exp Cell Res       Date:  2001-10-15       Impact factor: 3.905

6.  Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26.

Authors:  Yaara Ofir-Rosenfeld; Kristy Boggs; Dan Michael; Michael B Kastan; Moshe Oren
Journal:  Mol Cell       Date:  2008-10-24       Impact factor: 17.970

7.  Inhibition of HDM2 and activation of p53 by ribosomal protein L23.

Authors:  Aiwen Jin; Koji Itahana; Kevin O'Keefe; Yanping Zhang
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

8.  Essential role of ribosomal protein L11 in mediating growth inhibition-induced p53 activation.

Authors:  Krishna P Bhat; Koji Itahana; Aiwen Jin; Yanping Zhang
Journal:  EMBO J       Date:  2004-05-20       Impact factor: 11.598

9.  Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5.

Authors:  Mu-Shui Dai; Hua Lu
Journal:  J Biol Chem       Date:  2004-08-11       Impact factor: 5.157

Review 10.  Nedd8 on cullin: building an expressway to protein destruction.

Authors:  Zhen-Qiang Pan; Alex Kentsis; Dora C Dias; Kosj Yamoah; Kenneth Wu
Journal:  Oncogene       Date:  2004-03-15       Impact factor: 9.867

View more
  63 in total

1.  Perturbation of 60 S ribosomal biogenesis results in ribosomal protein L5- and L11-dependent p53 activation.

Authors:  Xiao-Xin Sun; Yue-Gang Wang; Dimitris P Xirodimas; Mu-Shui Dai
Journal:  J Biol Chem       Date:  2010-06-16       Impact factor: 5.157

Review 2.  The p53 orchestra: Mdm2 and Mdmx set the tone.

Authors:  Mark Wade; Yunyuan V Wang; Geoffrey M Wahl
Journal:  Trends Cell Biol       Date:  2010-02-19       Impact factor: 20.808

3.  The NEDD8 inhibitor MLN4924 increases the size of the nucleolus and activates p53 through the ribosomal-Mdm2 pathway.

Authors:  A Bailly; A Perrin; L J Bou Malhab; E Pion; M Larance; M Nagala; P Smith; M-F O'Donohue; P-E Gleizes; J Zomerdijk; A I Lamond; D P Xirodimas
Journal:  Oncogene       Date:  2015-04-13       Impact factor: 9.867

4.  Recognition and cleavage of related to ubiquitin 1 (Rub1) and Rub1-ubiquitin chains by components of the ubiquitin-proteasome system.

Authors:  Rajesh K Singh; Sylvia Zerath; Oded Kleifeld; Martin Scheffner; Michael H Glickman; David Fushman
Journal:  Mol Cell Proteomics       Date:  2012-10-26       Impact factor: 5.911

5.  NEDDylation regulates E2F-1-dependent transcription.

Authors:  Sarah J Loftus; Geng Liu; Simon M Carr; Shonagh Munro; Nicholas B La Thangue
Journal:  EMBO Rep       Date:  2012-07-27       Impact factor: 8.807

6.  Scission of the p53-MDM2 Loop by Ribosomal Proteins.

Authors:  Xiang Zhou; Jun-Ming Liao; Wen-Juan Liao; Hua Lu
Journal:  Genes Cancer       Date:  2012-03

Review 7.  Ribosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implications.

Authors:  Wei Wang; Subhasree Nag; Xu Zhang; Ming-Hai Wang; Hui Wang; Jianwei Zhou; Ruiwen Zhang
Journal:  Med Res Rev       Date:  2014-08-28       Impact factor: 12.944

8.  mTOR inhibitors blunt the p53 response to nucleolar stress by regulating RPL11 and MDM2 levels.

Authors:  Kaveh M Goudarzi; Monica Nistér; Mikael S Lindström
Journal:  Cancer Biol Ther       Date:  2014       Impact factor: 4.742

9.  Silencing of ribosomal protein S9 elicits a multitude of cellular responses inhibiting the growth of cancer cells subsequent to p53 activation.

Authors:  Mikael S Lindström; Monica Nistér
Journal:  PLoS One       Date:  2010-03-08       Impact factor: 3.240

Review 10.  The nucleolus under stress.

Authors:  Séverine Boulon; Belinda J Westman; Saskia Hutten; François-Michel Boisvert; Angus I Lamond
Journal:  Mol Cell       Date:  2010-10-22       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.